3 recruiting. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 3 |
| Phase 2 | 1 | Recruiting 1 |
Follow Hyperuricemia: new trials by email Literature Review of Hyperuricemia trials Research Report on Hyperuricemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Dotinurad Versus Allopurinol in Tophaceous Gout Allopurinol, Dotinurad - Tophaceous Gout | Phase 3 | Recruiting | Crystalys Therapeutics | 250 | 2025-08-04 | 2026-10-29 |
| A Study of Dotinurad Versus Allopurinol in Participants With Gout Allopurinol, Dotinurad - Gout | Phase 3 | Recruiting | Crystalys Therapeutics | 500 | 2025-08-01 | 2026-10-29 |
| Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare Dapansutrile, Placebo Tablet - Acute Gout Flare, Gout Attack | Phase 2 / Phase 3 | Recruiting | Olatec Therapeutics, Inc. | 300 | 2023-01-06 | 2026-03-11 |
Gout (2) · Arthralgia (1) · Arthritis (1) · Arthritis, Gouty (1) · Inflammation (1)
Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Crystal Arthropathies (2) · Genetic Diseases, Inborn (2) · Joint Diseases (2) · Metabolic Diseases (2) · Metabolism, Inborn Errors (2) · Musculoskeletal Diseases (2) · Nutritional and Metabolic Diseases (2) · Purine-Pyrimidine Metabolism, Inborn Errors (2) · Rheumatic Diseases (2) · Arthritis (1) · Neurologic Manifestations (1) · Pain (1)
Allopurinol (2) · dotinurad (2) · dapansutrile (1)
Crystalys Therapeutics (2) · Olatec Therapeutics, Inc. (1)
United States (3) · Spain (2) · France (1) · Israel (1) · Netherlands (1) · Poland (1)